Rheumatology and therapy.

Rheumatology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3-4 weeks from acceptance). The journal is dedicated to the publication of high-quality preclinical, clinical (all phases), observational, real-world, and health out...

Full description

Saved in:
Bibliographic Details
VerfasserIn:
Place / Publishing House:[London] : : Springer Healthcare,, [2014]-
Publication history:Began with Volume 1, Issue 1 (December 2014).
Language:English
Physical Description:1 online resource
Notes:Refereed/Peer-reviewed
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993574739304498
lccn 2016243015
ctrlnum (DE-599)ZDB2783278-8
(OCoLC)890026801
(CKB)3710000000219340
(CONSER)--2016243015
(NjHacI)993710000000219340
(EXLCZ)993710000000219340
collection bib_alma
record_format marc
spelling Springer Healthcare, author, issuing body.
RHEUMATOL THER
Rheumatol. ther.
Rheumatology and therapy.
[London] : Springer Healthcare, [2014]-
1 online resource
Two issues a year, 2015-
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Began with Volume 1, Issue 1 (December 2014).
Refereed/Peer-reviewed
Unrestricted online access star
Numbering from content page.
Volume 1 complete in 1 issue.
Rheumatology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3-4 weeks from acceptance). The journal is dedicated to the publication of high-quality preclinical, clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of rheumatologic therapies. Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also encouraged.
Description based on Volume 1, Issue 1 (December 2014); title from journal homepage (publisher's website, viewed December 4, 2015).
Latest issue consulted: Volume 2, Issue 2 (December 2015) (viewed January 8, 2016).
Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis -- Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis -- Current Practice Patterns and Educational Needs of Rheumatologists Who Manage Patients with Rheumatoid Arthritis -- Mannitol Preserves the Viscoelastic Properties of Hyaluronic Acid in an In Vitro Model of Oxidative Stress.
Rheumatology. fast (OCoLC)fst01097048
Physical and Rehabilitation Medicine.
Rheumatology.
Rheumatic Diseases.
Rheumatism Physical therapy Periodicals.
Rheumatology Periodicals.
Periodical.
Periodicals. fast (OCoLC)fst01411641
2198-6576
language English
format Journal
author_corporate Springer Healthcare,
author_facet Springer Healthcare,
author_corporate_role VerfasserIn
author_sort Springer Healthcare,
title Rheumatology and therapy.
spellingShingle Rheumatology and therapy.
Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis -- Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis -- Current Practice Patterns and Educational Needs of Rheumatologists Who Manage Patients with Rheumatoid Arthritis -- Mannitol Preserves the Viscoelastic Properties of Hyaluronic Acid in an In Vitro Model of Oxidative Stress.
title_short RHEUMATOL THER
title_full Rheumatology and therapy.
title_fullStr Rheumatology and therapy.
title_full_unstemmed Rheumatology and therapy.
title_auth Rheumatology and therapy.
title_new Rheumatology and therapy.
title_sort rheumatology and therapy.
publisher Springer Healthcare,
publishDate 2014
physical 1 online resource
dateSpan Began with Volume 1, Issue 1 (December 2014).
contents Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis -- Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis -- Current Practice Patterns and Educational Needs of Rheumatologists Who Manage Patients with Rheumatoid Arthritis -- Mannitol Preserves the Viscoelastic Properties of Hyaluronic Acid in an In Vitro Model of Oxidative Stress.
issn 2198-6584
2198-6576
callnumber-first R - Medicine
callnumber-subject RC - Internal Medicine
callnumber-label RC925
callnumber-sort RC 3925 A1 S675 42014
genre Periodical.
Periodicals. fast (OCoLC)fst01411641
genre_facet Periodicals.
Periodical.
illustrated Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.74
dewey-sort 3616.74
dewey-raw 616.74
dewey-search 616.74
oclc_num 890026801
work_keys_str_mv AT springerhealthcare rheumatologyandtherapy
status_str n
ids_txt_mv (DE-599)ZDB2783278-8
(OCoLC)890026801
(CKB)3710000000219340
(CONSER)--2016243015
(NjHacI)993710000000219340
(EXLCZ)993710000000219340
carrierType_str_mv cr
is_hierarchy_title Rheumatology and therapy.
_version_ 1796652617904947201
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nas-a2200565-i-4500</leader><controlfield tag="001">993574739304498</controlfield><controlfield tag="005">20240119213020.0</controlfield><controlfield tag="006">m-----o--d--------</controlfield><controlfield tag="007">cr-|||||||||||</controlfield><controlfield tag="008">140901c20149999enk||-poo-----0----0eng-c</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a"> 2016243015</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">GBB5E7656</subfield><subfield code="2">bnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">101674543</subfield><subfield code="2">DNLM</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">2783278-8</subfield><subfield code="2">DE-600</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1056993626</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">017575480</subfield><subfield code="2">Uk</subfield></datafield><datafield tag="022" ind1=" " ind2=" "><subfield code="a">2198-6584</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)ZDB2783278-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)890026801</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)3710000000219340</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CONSER)--2016243015</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)993710000000219340</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)993710000000219340</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="042" ind1=" " ind2=" "><subfield code="a">pcc</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC925.A1</subfield><subfield code="b">.S675 2014</subfield></datafield><datafield tag="060" ind1="0" ind2="0"><subfield code="a">W1</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.74</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.83</subfield><subfield code="2">bcl</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">Springer Healthcare,</subfield><subfield code="e">author,</subfield><subfield code="e">issuing body.</subfield></datafield><datafield tag="210" ind1=" " ind2=" "><subfield code="a">RHEUMATOL THER</subfield></datafield><datafield tag="210" ind1="0" ind2=" "><subfield code="a">Rheumatol. ther.</subfield></datafield><datafield tag="222" ind1=" " ind2="0"><subfield code="a">Rheumatology and therapy.</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Rheumatology and therapy.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[London] :</subfield><subfield code="b">Springer Healthcare,</subfield><subfield code="c">[2014]-</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="310" ind1=" " ind2=" "><subfield code="a">Two issues a year,</subfield><subfield code="b">2015-</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="362" ind1="1" ind2=" "><subfield code="a">Began with Volume 1, Issue 1 (December 2014).</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Refereed/Peer-reviewed</subfield></datafield><datafield tag="506" ind1="0" ind2=" "><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="515" ind1=" " ind2=" "><subfield code="a">Numbering from content page.</subfield></datafield><datafield tag="515" ind1=" " ind2=" "><subfield code="a">Volume 1 complete in 1 issue.</subfield></datafield><datafield tag="520" ind1="0" ind2=" "><subfield code="a">Rheumatology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3-4 weeks from acceptance). The journal is dedicated to the publication of high-quality preclinical, clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of rheumatologic therapies. Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also encouraged.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on Volume 1, Issue 1 (December 2014); title from journal homepage (publisher's website, viewed December 4, 2015).</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Latest issue consulted: Volume 2, Issue 2 (December 2015) (viewed January 8, 2016).</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis -- Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis -- Current Practice Patterns and Educational Needs of Rheumatologists Who Manage Patients with Rheumatoid Arthritis -- Mannitol Preserves the Viscoelastic Properties of Hyaluronic Acid in an In Vitro Model of Oxidative Stress.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Rheumatology.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst01097048</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Physical and Rehabilitation Medicine.</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Rheumatology.</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Rheumatic Diseases.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Rheumatism</subfield><subfield code="x">Physical therapy</subfield><subfield code="v">Periodicals.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Rheumatology</subfield><subfield code="v">Periodicals.</subfield></datafield><datafield tag="655" ind1=" " ind2="2"><subfield code="a">Periodical.</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Periodicals.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst01411641</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="x">2198-6576</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">JOURNAL</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-03-01 01:46:08 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2014-08-10 02:12:22 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAJ Directory of Open Access Journals</subfield><subfield code="P">DOAJ Directory of Open Access Journals</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5342031920004498&amp;Force_direct=true</subfield><subfield code="Z">5342031920004498</subfield><subfield code="m"> Available from 2014.</subfield><subfield code="b">Available</subfield><subfield code="8">5342031920004498</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="Z">5342031920004498</subfield><subfield code="A">2014</subfield></datafield></record></collection>